Zydus Lifesciences gets USFDA nod to sell generic anti-epileptic medication

Zydus Lifesciences has received approval from the US FDA to market Lacosamide Tablets, a generic anti-epileptic medication used to treat partial-onset seizures and primary generalized tonic-clonic seizures. The product will be manufactured at the company's manufacturing facility in Ahmedabad.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/1uDcMxS
via IFTTT